---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-051692"
form_type: "8-K/A"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2023-06-26T23:59:59+00:00"
generated_at: "2026-06-13T17:09:38.574098+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SS Innovations completes reverse merger with CardioVentures; acquiree shows $3.4M loss, going concern doubt

## Summary
- Merger closed April 14, 2023; CardioVentures shareholders received 135.8M shares (≈95% of SSII post-merger).
- Dr. Sudhir Srivastava becomes controlling shareholder, Chairman and CEO; new management team appointed.
- CardioVentures 2022 revenue $1.46M, net loss $3.39M; accumulated deficit $3.7M.
- Auditor expresses substantial doubt about CardioVentures' ability to continue as going concern.
- Company issued 3.82M shares to Dr. Frederic Moll for $3M interim financing.

## SEC filing metadata
- accession: 0001213900-23-051692
- form_type: 8-K/A
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2023-06-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.01, 3.02, 5.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390023051692/0001213900-23-051692-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390023051692/ea180745-8ka1_ssinnova.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-051692
- JSON: https://secwatch.observer/filing/0001213900-23-051692.json
- Plain text: https://secwatch.observer/filing/0001213900-23-051692.txt

## Key facts
- M&A Transactions
  SS Innovations International, Inc. underwent a change of control involving CardioVentures, Inc. for 135,808,884 shares of SSII common stock and shares of Series A Non-Convertible Preferred Stock (closed 2023-04-14).
  - Action: change of control
  - Counterparty: CardioVentures, Inc.
  - Consideration: 135,808,884 shares of SSII common stock and shares of Series A Non-Convertible Preferred Stock
  - Closing: 2023-04-14
  source text: Based in Haryana, common stock of CardioVentures (including certain parties who provided interim convertible financing during the pendency of the Merger Agreement, were issued 135,808,884 shares of SSII common stock, representing approximately 95% of issued and outstanding shares of SSII common stock post-Merger, with the existing shareholders of SSII holding
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390023051692/0001213900-23-051692-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.